<p>The solid line represents the observed proportion with a more than 50% reduction in seizure frequency, and the solid area represents the 95% prediction interval. PK, pharmacokinetic; PD, pharmacodynamics; VPA, valproic acid.</p
<p>Visual predictive check for the PK-PD model of peginesatide using traditional visual predictive c...
Objectives To set up a population pharmacokinetics (PPK) model of valproate (VPA) monotherapy in Chi...
<p>(A) Prediction-corrected visual predictive check of the lumefantrine population pharmacokinetic m...
Dots represent the observed linezolid concentrations; the solid lines correspond to the 5th, 50th, a...
Visual predictive check plots for (A) immediate-release (IR) tablet and (B) gastroretentive (GR) sys...
AIM: Using sparse data of valproate (VPA) serum concentrations to build a population pharmacokinetic...
The visual predictive checks were simulated for 1,000 patients and are shown for all 7 drugs and 9 l...
<p>(<b>a</b>) Visual predicive check (VPC) of the pharmacokinetic behavior using the posterior distr...
Using defined critical PK/PD exposure values, a population of 1,000 simulated patients were defined ...
<p>Visual predictive checks showing the medians (black lines) and corresponding 90% prediction inter...
Partial response in green (A), stable disease in blue (B), or progressive disease in red (C). Solid ...
Objectives: Valproic acid (VPA) is a broad spectrum antiepileptic drug with known efficacy profile i...
A visual predictive check (VPC) is a common diagnostic procedure for population pharmacometric model...
<p>Upper left: visual predictive check for peginesatide PK model following intravenous administratio...
<p>Visual Predictive Check (VPC) for each of the 5 groups (panel A for NGT, IFG and IGT; panel B for...
<p>Visual predictive check for the PK-PD model of peginesatide using traditional visual predictive c...
Objectives To set up a population pharmacokinetics (PPK) model of valproate (VPA) monotherapy in Chi...
<p>(A) Prediction-corrected visual predictive check of the lumefantrine population pharmacokinetic m...
Dots represent the observed linezolid concentrations; the solid lines correspond to the 5th, 50th, a...
Visual predictive check plots for (A) immediate-release (IR) tablet and (B) gastroretentive (GR) sys...
AIM: Using sparse data of valproate (VPA) serum concentrations to build a population pharmacokinetic...
The visual predictive checks were simulated for 1,000 patients and are shown for all 7 drugs and 9 l...
<p>(<b>a</b>) Visual predicive check (VPC) of the pharmacokinetic behavior using the posterior distr...
Using defined critical PK/PD exposure values, a population of 1,000 simulated patients were defined ...
<p>Visual predictive checks showing the medians (black lines) and corresponding 90% prediction inter...
Partial response in green (A), stable disease in blue (B), or progressive disease in red (C). Solid ...
Objectives: Valproic acid (VPA) is a broad spectrum antiepileptic drug with known efficacy profile i...
A visual predictive check (VPC) is a common diagnostic procedure for population pharmacometric model...
<p>Upper left: visual predictive check for peginesatide PK model following intravenous administratio...
<p>Visual Predictive Check (VPC) for each of the 5 groups (panel A for NGT, IFG and IGT; panel B for...
<p>Visual predictive check for the PK-PD model of peginesatide using traditional visual predictive c...
Objectives To set up a population pharmacokinetics (PPK) model of valproate (VPA) monotherapy in Chi...
<p>(A) Prediction-corrected visual predictive check of the lumefantrine population pharmacokinetic m...